Device Trial Radar · NCT06019845
The MAGiC™ Cardiac Ablation European Study
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jan 2, 2024
Primary completion
Dec 31, 2027
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- StereotaxisPublic (STXS)
- Sponsor type
- Industry
- Collaborators
- Osypka AG
- First posted
- Aug 31, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval. The purpose of MAGiC-FEST PMCF Study is to collect safety and performance data with MAGiC to meet ongoing regulatory obligations.
Conditions
- Arrhythmias, Cardiac
Interventions
MAGiC™Device
Robotic magnetic radiofrequency (RF) ablation catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acute PerformanceTime frame: hospital discharge - up to 7 days post procedure
- Acute SafetyTime frame: hospital discharge - up to 7 days post procedure
Locations
4 sites in 4 countries. Site status is shown where the registry gives one.
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark · Recruiting
Vilniaus universiteto ligoninė Santaros klinikos
Vilnius, Lithuania · Recruiting
Erasmus Medical Center
Rotterdam, Netherlands · Not yet recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.